Alliance Wealth Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$267K Sell
223
-5
-2% -$5.11K 0.05% 85
2026
Q1
$210K Buy
228
+25
+12% +$25.3K 0.05% 93
2025
Q4
$218K Buy
+203
New +$194K 0.05% 91

Other funds holding LLY

Alliance Wealth Management Group's LLY Position: Q2 2026 in Review

Alliance Wealth Management Group reduced its Eli Lilly (LLY) stake by 2.2% in Q2 2026, selling an estimated $5.11K and leaving 223 shares worth $267K. The position accounts for 0.05% of the portfolio, ranked #85.

Alliance Wealth Management Group first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Alliance Wealth Management Group held 223 shares of Eli Lilly worth $267K as of Q2 2026.
  • Alliance Wealth Management Group sold 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 0.05% of Alliance Wealth Management Group's portfolio in Q2 2026, its #85 holding.
  • Alliance Wealth Management Group first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Alliance Wealth Management Group's 13F filing for Q2 2026, filed 4 Aug 2026.